{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:44:43Z","timestamp":1791582283358,"version":"4.3.4"},"reference-count":227,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904191"],"award-info":[{"award-number":["81904191"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.phrs.2022.106152","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:35:24Z","timestamp":1646372124000},"page":"106152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Role of puerarin in pathological cardiac remodeling: A review"],"prefix":"10.1016","volume":"178","author":[{"given":"Jiayu","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.57.1.84","article-title":"Influence of chronic captopril therapy on the infarcted left ventricle of the rat","volume":"57","author":"Pfeffer","year":"1985","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9149(84)90206-6","article-title":"Early and late remodeling of the left ventricle after acute myocardial infarction","volume":"54","author":"Roberts","year":"1984","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib5","article-title":"Association between myocardial mechanics and ischemic LV remodeling","volume":"8","author":"D\u2019Elia","year":"2015","journal-title":"JACC: Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2010.04.005","article-title":"Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies","volume":"128","author":"Bernardo","year":"2010","journal-title":"Pharmacol. Ther."},{"issue":"9932","key":"10.1016\/j.phrs.2022.106152_bib8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-020-00435-x","article-title":"Myocarditis and inflammatory cardiomyopathy: current evidence and future directions","volume":"18","author":"Tsch\u00f6pe","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"27","key":"10.1016\/j.phrs.2022.106152_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib11","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2007.1474","article-title":"Cardiac hypertrophy: mechanisms and therapeutic opportunities","volume":"9","author":"Gupta","year":"2007","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/j.2040-4603.2015.tb00664.x","article-title":"Pathophysiology of myocardial infarction","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.hfc.2011.08.005","article-title":"Pressure overload","volume":"vol. 8","author":"Frohlich","year":"2012","journal-title":"Heart Fail. Clin."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib14","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.14132746","article-title":"Effect of infarct severity on regional and global left ventricular remodeling in patients with successfully reperfused st segment elevation myocardial infarction","volume":"274","author":"Symons","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.1218","article-title":"Serial cine-magnetic resonance imaging of left ventricular remodeling after myocardial infarction in rats","volume":"14","author":"Nahrendorf","year":"2001","journal-title":"J. Magn. Reson. Imaging"},{"issue":"SUPPL. B","key":"10.1016\/j.phrs.2022.106152_bib16","article-title":"Mechanisms of myocyte and capillary growth in the infarcted heart","volume":"11","author":"Anversa","year":"1990","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000046449.36178.00","article-title":"Myocardial infarct expansion and matrix metalloproteinase inhibition","volume":"107","author":"Mukherjee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106152_bib18","doi-asserted-by":"crossref","unstructured":"\u201cErratum: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (1789\u20131858), (S0140673618322797), (10.1016\/S0140\u20136736(18)32279\u20137)), The Lancet, vol. 393, no. 10190. 2019, doi:10.1016\/S0140\u20136736(19)31047\u20135.","DOI":"10.1016\/S0140-6736(19)31047-5"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: The prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review","volume":"18","author":"Van Riet","year":"2016","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.phrs.2022.106152_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1569","article-title":"Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise","volume":"21","author":"Moliner","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"9266","key":"10.1016\/j.phrs.2022.106152_bib21","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106152_bib22","doi-asserted-by":"crossref","unstructured":"\u201cEffect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial, J. Cardiothorac. Vasc. Anesth., vol. 7, no. 2, 1993, doi:10.1016\/1053\u20130770(93)90231\u20139.","DOI":"10.1016\/1053-0770(93)90231-9"},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2005.09.055","article-title":"The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the valsartan in acute myocardial infarction trial (VALIANT)","volume":"47","author":"McMurray","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2003.10.031","article-title":"Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: results of the Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan (OPTIMAAL) echocardiographic substudy","volume":"147","author":"M\u00f8ller","year":"2004","journal-title":"Am. Heart J."},{"issue":"20","key":"10.1016\/j.phrs.2022.106152_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib26","doi-asserted-by":"crossref","DOI":"10.1039\/b514294f","article-title":"Natural products to drugs: natural product-derived compounds in clinical trials","volume":"25","author":"Butler","year":"2008","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phrs.2022.106152_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107698","article-title":"Current state and future perspective of cardiovascular medicines derived from natural products","volume":"216","author":"Zhao","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib28","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib29","doi-asserted-by":"crossref","DOI":"10.1039\/C4NP00064A","article-title":"Natural product and natural product derived drugs in clinical trials","volume":"31","author":"Butler","year":"2014","journal-title":"Nat. Prod. Rep."},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib30","doi-asserted-by":"crossref","DOI":"10.1142\/S0192415X18500891","article-title":"Management of diabetes mellitus with puerarin, a natural isoflavone from pueraria lobata","volume":"46","author":"Chen","year":"2018","journal-title":"Am. J. Chin. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib31","doi-asserted-by":"crossref","DOI":"10.1124\/pr.115.010843","article-title":"Botanicals and their bioactive phytochemicals for women\u2019s health","volume":"68","author":"Dietz","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib32","doi-asserted-by":"crossref","DOI":"10.2174\/1871520620666200227091811","article-title":"A critical review on anticancer mechanisms of natural flavonoid puerarin","volume":"20","author":"Murahari","year":"2020","journal-title":"Anticancer. Agents Med. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.5083","article-title":"Puerarin: a review of pharmacological effects","volume":"28","author":"Zhou","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2022.106152_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104625","article-title":"The beneficial health effects of flavonoids on the cardiovascular system: Focus on K+ channels","volume":"152","author":"Fusi","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2019.1660732","article-title":"Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine","volume":"26","author":"Zhang","year":"2019","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib36","doi-asserted-by":"crossref","DOI":"10.1166\/jbn.2018.2483","article-title":"A supramolecular hydrogel of puerarin","volume":"14","author":"Cai","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.phrs.2022.106152_bib37","unstructured":"N.S. Editionh, X.U. Bei, W. Xu, and W.U. Di Pharmacokinetic study of puerarin in rats after oral administration, 2018, doi:10.19492\/j.cnki.1672\u20130946.2018.06.002."},{"issue":"19","key":"10.1016\/j.phrs.2022.106152_bib38","article-title":"Pharmaceutics research advances in oral administration of puerarin","volume":"44","author":"Wu","year":"2019","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.phrs.2022.106152_bib39","first-page":"1715","article-title":"C S Study on the absorption mechanism of geranium in the rat intestinal canal ectopia model","volume":"07","author":"Cui","year":"2008","journal-title":"Shi-Zhen Guomao Guomao"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2006.01.013","article-title":"Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model","volume":"41","author":"Ruan","year":"2006","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2022.106152_bib41","article-title":"Transport properties of puerarin and effect of extract of radix Angelicae dahuricae on puerarin intestinal absorption using in situ and in vitro models","volume":"28","author":"Liao","year":"2014","journal-title":"Phyther. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2014.03.170","article-title":"Comparison of two approaches of intestinal absorption by puerarin","volume":"vol. 70","author":"Li","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.phrs.2022.106152_bib43","unstructured":"U.O. Yu A Brief Review on Herbal Pharmacokinetics Study for Puerarin and Flavone of Radix puerariae lobatae, vol. 12, pp. 82\u201385, 2009."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22060939","article-title":"Pharmacokinetics and tissue distribution kinetics of puerarin in rats using indirect competitive ELISA","volume":"22","author":"Kong","year":"2017","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib45","article-title":"Pharmacokinetics of puerarin in the aqueous humor and vitreous of rabbit eye following systemic administration","volume":"22","author":"Deng","year":"2006","journal-title":"Yan Ke Xue Bao"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib46","article-title":"Pharmacokinetics of puerarin in pregnant rats at different stages of gestation after oral administration","volume":"86","author":"Cao","year":"2013","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib47","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-018-0216-3","article-title":"Absolute oral bioavailability and disposition kinetics of puerarin in female rats","volume":"19","author":"Anukunwithaya","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2022.106152_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2017.02.029","article-title":"RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model","volume":"89","author":"Dong","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib49","doi-asserted-by":"crossref","DOI":"10.1248\/bpb.21.628","article-title":"Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity","volume":"21","author":"Kim","year":"1998","journal-title":"Biol. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib50","doi-asserted-by":"crossref","DOI":"10.2174\/0929867013373011","article-title":"Flavonoid antioxidants","volume":"8","author":"Rice-Evans","year":"2012","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib51","doi-asserted-by":"crossref","DOI":"10.1248\/bpb.18.300","article-title":"Urinary and biliary metabolites of puerarin in rats","volume":"18","author":"Yasuda","year":"1995","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib52","article-title":"UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes","volume":"86","author":"Luo","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2022.106152_bib53","article-title":"Metabolites of puerarin identified by liquid chromatography tandem mass spectrometry: similar metabolic profiles in liver and intestine of rats","volume":"878","author":"Luo","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib54","doi-asserted-by":"crossref","DOI":"10.1021\/jf040037t","article-title":"Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry","volume":"52","author":"Prasain","year":"2004","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s00217-009-1156-3","article-title":"Toxicological evaluation of the isoflavone puerarin and its glycosides","volume":"230","author":"Chung","year":"2009","journal-title":"Eur. Food Res. Technol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2009.07.004","article-title":"Impact effects of puerarin on mouse embryonic development","volume":"28","author":"Chen","year":"2009","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib57","doi-asserted-by":"crossref","DOI":"10.3109\/01480545.2015.1126842","article-title":"Apoptotic effects on maturation of mouse oocytes, fertilization and fetal development by puerarin","volume":"39","author":"Huang","year":"2016","journal-title":"Drug Chem. Toxicol."},{"issue":"02","key":"10.1016\/j.phrs.2022.106152_bib58","first-page":"33","article-title":"ZE A case of acute hemolytic anemia caused by Pueraria lobata injection","author":"Pei","year":"2004","journal-title":"Chin. Pharmacovigil."},{"issue":"09","key":"10.1016\/j.phrs.2022.106152_bib59","first-page":"780","article-title":"One case of anaphylaxis caused by Pueraria lobata injection","volume":"29","author":"Weiwei","year":"2009","journal-title":"Chin. J. Hosp. Pharm."},{"issue":"02","key":"10.1016\/j.phrs.2022.106152_bib60","first-page":"21","article-title":"Study on the adverse reactions of Pueraria lobata injection and analysis of related factors","volume":"3","author":"Jugen","year":"2009","journal-title":"China Mod. Drug Appl."},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/nrm1983","article-title":"Regulation of cardiac hypertrophy by intracellular signalling pathways","volume":"7","author":"Heineke","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"13","key":"10.1016\/j.phrs.2022.106152_bib62","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"New Engl. J. Med."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib63","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.186551","article-title":"Autophagy in load-induced heart disease","volume":"103","author":"Rothermel","year":"2008","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2022.106152_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib66","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2022.106152_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"vol. 65","author":"Frangogiannis","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: The master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.yjmcc.2010.10.033","article-title":"Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling","volume":"51","author":"Dobaczewski","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib70","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1006\/jmcc.1997.0457","article-title":"Differential protein expression and subcellular distribution of TGF\u03b21, \u03b22, and \u03b23 in cardiomyocytes during pressure overload-induced hypertrophy","volume":"29","author":"Li","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2022.106152_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2647129","article-title":"Puerarin protects against cardiac fibrosis associated with the inhibition of TGF-\u03b21\/Smad2-mediated endothelial-to-mesenchymal transition","volume":"2017","author":"Jin","year":"2017","journal-title":"PPAR Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/art.20104","article-title":"Disruption of transforming growth factor \u03b2 signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated Receptor \u03b3","volume":"50","author":"Ghosh","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.phrs.2022.106152_bib73","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jnutbio.2011.05.015","article-title":"Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-\u03b21 expression","volume":"23","author":"Chen","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.phrs.2022.106152_bib74","doi-asserted-by":"crossref","DOI":"10.1007\/s00011-019-01231-1","article-title":"Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib75","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-\u03b2 signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.phrs.2022.106152_bib76","first-page":"4425","article-title":"Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-\u03b21 (TGF-\u03b21) pathway in myocardial infarction mice","volume":"8","author":"Tao","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib77","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.106.646091","article-title":"Critical role of monocyte chemoattractant protein-1\/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy","volume":"115","author":"Frangogiannis","year":"2007","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000119170.70818.4F","article-title":"Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation","volume":"94","author":"Feinberg","year":"2004","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.phrs.2022.106152_bib79","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease","volume":"95","author":"Charo","year":"2004","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib80","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib81","doi-asserted-by":"crossref","DOI":"10.1023\/B:HREV.0000011393.40674.13","article-title":"Regulation of matrix metalloproteinases by cytokines and reactive oxygen\/nitrogen species in the myocardium","volume":"9","author":"Siwik","year":"2004","journal-title":"Heart Fail. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib82","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1161\/01.RES.86.12.1259","article-title":"Interleukin-1 \u03b2 and tumor necrosis factor-\u03b1 decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro","volume":"86","author":"Siwik","year":"2000","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib83","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","article-title":"Tumor necrosis factor-\u03b1 mediates cardiac remodeling and ventricular dysfunction after pressure overload state","volume":"115","author":"Sun","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib84","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/HJH.0000000000000358","article-title":"Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunctionwithout affecting blood pressure in angiotensin II-high salt-induced hypertension","volume":"33","author":"Gonz\u00e1lez","year":"2015","journal-title":"J. Hypertens."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.308688","article-title":"Deletion of interleukin-6 attenuates pressure overload-induced left ventricular hypertrophy and dysfunction","volume":"118","author":"Zhao","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib86","doi-asserted-by":"crossref","DOI":"10.2353\/ajpath.2008.070974","article-title":"Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling","volume":"173","author":"Bujak","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib87","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/01.CIR.95.5.1247","article-title":"Tumor necrosis factor-\u03b1 provokes a hypertrophic growth response in adult cardiac myocytes","volume":"95","author":"Yokoyama","year":"1997","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib88","doi-asserted-by":"crossref","DOI":"10.1172\/JCI119114","article-title":"Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death","volume":"98","author":"Krown","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2006.05.059","article-title":"TNF-\u03b1-mediated cardiomyocyte apoptosis involves caspase-12 and calpain","volume":"345","author":"Bajaj","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2507","article-title":"Ischemia and reperfusion-from mechanism to translation","volume":"17","author":"Eltzschig","year":"2011","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib91","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12012-020-09571-9","article-title":"Puerarin alleviates lipopolysaccharide-induced myocardial fibrosis by inhibiting PARP-1 to prevent HMGB1-mediated TLR4-NF-\u03baB signaling pathway","volume":"20","author":"Ni","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib92","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvs018","article-title":"The innate immune response in reperfused myocardium","volume":"94","author":"Timmers","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib93","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis sumanth","volume":"119","author":"P","year":"2016","journal-title":"Physiol. Behav."},{"issue":"September","key":"10.1016\/j.phrs.2022.106152_bib94","article-title":"Puerarin protects against myocardial ischemia\/reperfusion injury by inhibiting inflammation and the NLRP3 inflammasome: the role of the SIRT1\/NF-\u03baB pathway","volume":"89","author":"Wang","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib95","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.1999.79.1.143","article-title":"Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human","volume":"79","author":"Widmann","year":"1999","journal-title":"Physiol. Rev."},{"issue":"12 A","key":"10.1016\/j.phrs.2022.106152_bib96","article-title":"Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists","volume":"83","author":"Clerk","year":"1999","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib97","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/S0898-6568(01)00192-9","article-title":"Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity","volume":"13","author":"Liebmann","year":"2001","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.83.4.345","article-title":"\u2018Stress-responsive\u2019 mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium","volume":"83","author":"Sugden","year":"1998","journal-title":"Circ. Res."},{"issue":"21","key":"10.1016\/j.phrs.2022.106152_bib100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.211086598","article-title":"The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy","volume":"98","author":"Liao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib101","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000035854.11082.01","article-title":"c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes","volume":"91","author":"Petrich","year":"2002","journal-title":"Circ. Res."},{"issue":"15","key":"10.1016\/j.phrs.2022.106152_bib102","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M314142200","article-title":"Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects","volume":"279","author":"Petrich","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.phrs.2022.106152_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/19.23.6341","article-title":"The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice","volume":"19","author":"Bueno","year":"2000","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib104","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/aps.2013.185","article-title":"Puerarin inhibits angiotensin II-induced cardiac hypertrophy via the redox-sensitive ERK1\/2, p38 and NF-\u03baB pathways","volume":"35","author":"Chen","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.18433\/J3N318","article-title":"Puerarin suppresses angiotensin II-induced cardiac hypertrophy by inhibiting NADPH oxidase activation and oxidative stress-triggered AP-1 signaling pathways","volume":"18","author":"Chen","year":"2015","journal-title":"J. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/S0955-0674(97)80068-3","article-title":"AP-1 function and regulation","volume":"9","author":"Karin","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"issue":"1336","key":"10.1016\/j.phrs.2022.106152_bib107","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"351","author":"Karin","year":"1996","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib109","first-page":"41","article-title":"Puerarin attenuates angiotensin II-induced cardiac fibroblast proliferation via the promotion of catalase activity and the inhibition of hydrogen peroxide-dependent Rac-1 activation","volume":"16","author":"Chen","year":"2018","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.phrs.2022.106152_bib110","first-page":"1","article-title":"Nrf2 is a key regulator on puerarin preventing cardiac fibrosis and upregulating metabolic enzymes UGT1A1 in rats","author":"Cai","year":"2018","journal-title":"Front. Pharmacol"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib111","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mtor signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2016.01.003","article-title":"mTOR, cardiomyocytes and inflammation in cardiac hypertrophy","volume":"1863","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.111.249532","article-title":"Differential roles of gsk-3\u03b2 during myocardial ischemia and ischemia\/reperfusion","volume":"vol. 109","author":"Zhai","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/emmm.201303183","article-title":"PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity","volume":"6","author":"V\u00f6lkers","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib117","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbrc.2015.07.065","article-title":"Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy","volume":"464","author":"Liu","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5712","key":"10.1016\/j.phrs.2022.106152_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib119","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jjcc.2013.06.008","article-title":"Puerarin attenuates pressure overload-induced cardiac hypertrophy","volume":"63","author":"Yuan","year":"2014","journal-title":"J. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2008.01.004","article-title":"Phosphatases at the heart of FoxO metabolic control","volume":"7","author":"Tremblay","year":"2008","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib121","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.106.637124","article-title":"Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling","volume":"114","author":"Ni","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2022.106152_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173472","article-title":"Puerarin attenuates the endothelial-mesenchymal transition induced by oxidative stress in human coronary artery endothelial cells through PI3K\/AKT pathway","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol"},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcm.2012.03.008","article-title":"Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease","volume":"21","author":"Ali","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib124","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.phrs.2022.106152_bib125","article-title":"Cell death in disease: mechanisms and emerging therapeutic concepts","volume":"361","author":"Hotchkiss","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2004.07.005","article-title":"Role of apoptosis in remodeling after myocardial infarction","volume":"104","author":"Takemura","year":"2004","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib127","doi-asserted-by":"crossref","DOI":"10.1023\/A:1011335525219","article-title":"Progressively developed myocardial apoptotic cell death during late phase of reperfusion","volume":"6","author":"Zhao","year":"2001","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.phrs.2022.106152_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.452","article-title":"Co-expression of POU4F2\/Brn-3b with p53 may be important for controlling expression of pro-apoptotic genes in cardiomyocytes following ischaemic\/hypoxic insults","volume":"5","author":"Budhram-Mahadeo","year":"2014","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)64598-1","article-title":"Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis","volume":"157","author":"Leri","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib130","doi-asserted-by":"crossref","DOI":"10.1161\/hy0102.100788","article-title":"Stimulation of cardiac apoptosis in essential\u00a0hypertension potential role of angiotensin II","volume":"39","author":"Gonz\u00e1lez","year":"2002","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/j.1440-1681.2009.05243.x","article-title":"Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure","volume":"36","author":"Li","year":"2009","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"5 41\u20135","key":"10.1016\/j.phrs.2022.106152_bib132","article-title":"Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat","volume":"272","author":"Li","year":"1997","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/S0008-6363(03)00498-X","article-title":"Cardiomyocyte apoptosis in hypertensive cardiomyopathy","volume":"59","author":"Gonz\u00e1lez","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/S0008-6363(02)00442-X","article-title":"Myocardial apoptosis and ischemic preconditioning","volume":"55","author":"Zhao","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"22","key":"10.1016\/j.phrs.2022.106152_bib135","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.97.22.2259","article-title":"Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy","volume":"97","author":"Vakeva","year":"1998","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.phrs.2022.106152_bib136","doi-asserted-by":"crossref","DOI":"10.1089\/10430340152677403","article-title":"Blocking caspase-activated apoptosis improves contractility in failing myocardium","volume":"12","author":"Laugwitz","year":"2001","journal-title":"Hum. Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib137","first-page":"719","article-title":"MicroRNA-21 contributes to the puerarin-induced cardioprotection via suppression of apoptosis and oxidative stress in a cell model of ischemia\/reperfusion injury","volume":"20","author":"Xu","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib138","doi-asserted-by":"crossref","DOI":"10.1007\/s10439-020-02659-x","article-title":"Mechanical regulation of apoptosis in the cardiovascular system","volume":"49","author":"Goldblatt","year":"2021","journal-title":"Ann. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib139","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol. Rev."},{"issue":"21","key":"10.1016\/j.phrs.2022.106152_bib140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.958033","article-title":"Silent information regulator 1 protects the heart from ischemia\/reperfusion","volume":"122","author":"Hsu","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"56","key":"10.1016\/j.phrs.2022.106152_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.phrs.2022.106152_bib143","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.22.13.4929-4942.2002","article-title":"The bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH 2 -terminal kinase","volume":"22","author":"Lei","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib144","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0438011100","article-title":"JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis","volume":"100","author":"Lei","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.5","article-title":"JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure","volume":"3","author":"Chaanine","year":"2012","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.phrs.2022.106152_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075872","article-title":"Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia\/reperfusion injury via PTEN\/Akt pathway","volume":"8","author":"Tu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib147","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0803-3","article-title":"PTEN\/PTENP1: \u2018Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy","volume":"vol. 17","author":"Haddadi","year":"2018","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib148","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-009-0004-8","article-title":"The mitochondrial permeability transition pore and ischemia-reperfusion injury","volume":"104","author":"Baines","year":"2009","journal-title":"Basic Res. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2017.05.034","article-title":"Basic biology of oxidative stress and the cardiovascular system: part 1 of a 3-part series","volume":"70","author":"Sack","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2022.106152_bib150","article-title":"Improvement of ventricular mechanical properties by puerarin involves mitochondrial permeability transition in isolated rat heart during ischemia and reperfusion","volume":"7","author":"Gao","year":"2005","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Proc."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2005.12.040","article-title":"Atractyloside and 5-hydroxydecanoate block the protective effect of puerarin in isolated rat heart","volume":"79","author":"Gao","year":"2006","journal-title":"Life Sci."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2022.106152_bib152","article-title":"Opening the calcium-activated potassium channel participates in the cardioprotective effect of puerarin","volume":"574","author":"Gao","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib153","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3026","article-title":"The protective effects of puerarin in cardiomyocytes from anoxia\/reoxygenation injury are mediated by PKC\u03b5","volume":"32","author":"Tang","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib154","first-page":"455","article-title":"protective role and the mechanisms of puerarin on isolated rat heart during ischemia\/reperfusion","volume":"22","author":"Pan","year":"2006","journal-title":"Zhongguo Ying Yong Sheng Li Xue Za Zhi"},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib155","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000245106.80628.d3","article-title":"Mitochondrial PKC\u03b5 and mitochondrial ATP-sensitive K+ channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes","volume":"99","author":"Jab\u016frek","year":"2006","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib156","doi-asserted-by":"crossref","DOI":"10.1042\/BST0351052","article-title":"Mitochondrial protein kinase C\u03b5 (PKC\u03b5): emerging role in cardiac protection from ischaemic damage","volume":"35","author":"Budas","year":"2007","journal-title":"Biochem. Soc. Trans."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/S0008-6363(02)00455-8","article-title":"Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?","volume":"55","author":"Hausenloy","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"5595","key":"10.1016\/j.phrs.2022.106152_bib158","doi-asserted-by":"crossref","DOI":"10.1126\/science.1074360","article-title":"Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane","volume":"298","author":"Xu","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/cdd.2008.163","article-title":"The role of autophagy in the heart","volume":"16","author":"Nishida","year":"2009","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib160","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvz152","article-title":"TXNIP\/Redd1 signalling and excessive autophagy: a novel mechanism of myocardial ischaemia\/reperfusion injury in mice","volume":"116","author":"Gao","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib161","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.108.187427","article-title":"Autophagy in ischemic heart disease","volume":"104","author":"Gustafsson","year":"2009","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib162","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvr358","article-title":"Autophagy as a therapeutic target for ischaemia\/reperfusion injury? Concepts, controversies, and challenges","volume":"94","author":"Przyklenk","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib163","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.3892\/mmr.2017.6424","article-title":"Puerarin attenuates myocardial hypoxia\/reoxygenation injury by inhibiting autophagy via the Akt signaling pathway","volume":"15","author":"Tang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib164","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00441-021-03463-2","article-title":"Puerarin protects cardiomyocytes from ischemia\u2013reperfusion injury by upregulating LncRNA ANRIL and inhibiting autophagy","volume":"385","author":"Han","year":"2021","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib165","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000261924.76669.36","article-title":"Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of AMP-activated protein kinase and beclin 1 in mediating autophagy","volume":"100","author":"Matsui","year":"2007","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib166","article-title":"Insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes through AKT\/FOXO signaling","volume":"45","author":"Paula-Gomes","year":"2013","journal-title":"Horm. Metab. Res."},{"issue":"8","key":"10.1016\/j.phrs.2022.106152_bib167","doi-asserted-by":"crossref","DOI":"10.1142\/S0192415X21500907","article-title":"Ginsenoside Rb1 inhibits cardiomyocyte autophagy via PI3K\/Akt\/mTOR signaling pathway and reduces myocardial ischemia\/reperfusion injury","volume":"49","author":"Qin","year":"2021","journal-title":"Am. J. Chin. Med."},{"issue":"9","key":"10.1016\/j.phrs.2022.106152_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092090","article-title":"Oxidative stress in cardiovascular diseases: still a therapeutic target?","volume":"11","author":"Senoner","year":"2019","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib169","doi-asserted-by":"crossref","DOI":"10.3390\/ijms15046002","article-title":"Oxidative stress in cardiovascular disease","volume":"15","author":"Cs\u00e1nyi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib170","doi-asserted-by":"crossref","DOI":"10.3109\/15376516.2012.666650","article-title":"Oxidative stress and cardiac hypertrophy: a review","volume":"22","author":"Maulik","year":"2012","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.phrs.2022.106152_bib171","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1656450","article-title":"The role of oxidative stress in myocardial ischemia and reperfusion injury and remodeling: revisited","volume":"2016","author":"Kurian","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib172","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.phrs.2022.106152_bib173","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-mediated cellular signaling","volume":"2016","author":"Zhang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib174","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib175","doi-asserted-by":"crossref","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents","volume":"vol. 32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2022.106152_bib176","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6635460","article-title":"The keap1-Nrf2 system: a mediator between oxidative stress and aging","volume":"2021","author":"Yu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib177","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2018.0513","article-title":"The anti-inflammatory and anti-oxidant mechanisms of the keap1\/Nrf2\/ARE signaling pathway in chronic diseases","volume":"10","author":"Tu","year":"2019","journal-title":"Aging Dis."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib178","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1124\/jpet.118.248369","article-title":"Contributions of Nrf2 to puerarin prevention of cardiac hypertrophy and its metabolic enzymes expression in rats","volume":"366","author":"Zhao","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2022.106152_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780897","article-title":"hPMSCs-derived exosomal miRNA-21 protects against aging-related oxidative damage of CD4+ T cells by targeting the PTEN\/PI3K-Nrf2 axis","volume":"12","author":"Xiong","year":"2021","journal-title":"Front. Immunol."},{"issue":"45","key":"10.1016\/j.phrs.2022.106152_bib180","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M206911200","article-title":"Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib181","doi-asserted-by":"crossref","DOI":"10.1038\/nri1312","article-title":"NOX enzymes and the biology of reactive oxygen","volume":"4","author":"Lambeth","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/path.4255","article-title":"Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac\/NADPH oxidase","volume":"231","author":"Elnakish","year":"2013","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib183","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0b013e3182a18bcc","article-title":"Role of small GTPase protein Rac1 in cardiovascular diseases: Development of new selective pharmacological inhibitors","volume":"62","author":"Ferri","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"13","key":"10.1016\/j.phrs.2022.106152_bib184","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000091084.46500.BB","article-title":"Oxygen free radical, release in human failing myocardium is associated with increased activity of Rac1-GTPase and represents a target for statin treatment","volume":"108","author":"Maack","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib185","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.0000261657.76299.ff","article-title":"Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling\/dysfunction and survival after myocardial infarction","volume":"100","author":"Doerries","year":"2007","journal-title":"Circ. Res."},{"issue":"19","key":"10.1016\/j.phrs.2022.106152_bib186","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0510444103","article-title":"Requirement of Rac1 in the development of cardiac hypertrophy","volume":"103","author":"Satoh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib187","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.107.101980","article-title":"Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction","volume":"51","author":"Looi","year":"2008","journal-title":"Hypertension"},{"issue":"34","key":"10.1016\/j.phrs.2022.106152_bib188","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.381517","article-title":"Angiotensin-II and marcks: a hydrogen peroxide- and Rac1-dependent signaling pathway in vascular endothelium","volume":"287","author":"Kalwa","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib189","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvn280","article-title":"Mitochondrial oxidative stress and dysfunction in myocardial remodelling","volume":"81","author":"Tsutsui","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib190","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.65.5.245","article-title":"Oxygen free radicals and congestive heart failure","volume":"65","author":"Belch","year":"1991","journal-title":"Br. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib191","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvx017","article-title":"Metabolismin cardiomyopathy: every substrate matters","volume":"113","author":"Ritterhoff","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib192","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvn116","article-title":"Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease","volume":"79","author":"Schwenk","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2012.06.006","article-title":"Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets","volume":"135","author":"Hou","year":"2012","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2022.106152_bib194","article-title":"Metabolic modulators in heart disease: past, present, and future","volume":"33","author":"Lopaschuk","year":"2017","journal-title":"Can. J. Cardiol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib195","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMra063052","article-title":"The failing heart \u2014 an engine out of fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib196","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib197","doi-asserted-by":"crossref","DOI":"10.1038\/sj.embor.7400584","article-title":"Glucose transporter 4: cycling, compartments and controversies","volume":"6","author":"Dugani","year":"2005","journal-title":"EMBO Rep."},{"issue":"15","key":"10.1016\/j.phrs.2022.106152_bib198","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-011-0690-x","article-title":"Subcellular trafficking of the substrate transporters GLUT4 and CD36 in cardiomyocytes","volume":"68","author":"Steinbusch","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib199","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbrc.2015.06.067","article-title":"Puerarin improves cardiac function through regulation of energy metabolism in Streptozotocin-Nicotinamide induced diabetic mice after myocardial infarction","volume":"463","author":"Cheng","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"15","key":"10.1016\/j.phrs.2022.106152_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.febslet.2009.07.008","article-title":"Differential effects of chronic, in vivo, PPAR\u2019s stimulation on the myocardial subcellular redistribution of FAT\/CD36 and FABPpm","volume":"583","author":"Kalinowska","year":"2009","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib201","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.e10-08-0665","article-title":"A Ral GAP complex links PI 3-kinase\/Akt signaling to RalA activation in insulin action","volume":"22","author":"Chen","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib202","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/FJC.0000000000000431","article-title":"Puerarin Suppresses Na+-K+-ATPase-Mediated Systemic Inflammation and CD36 Expression, and Alleviates Cardiac Lipotoxicity in Vitro and in Vivo","volume":"68","author":"Qin","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib203","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000000311","article-title":"Low-dose exogenous ouabain alleviates cardiac lipotoxicity through suppressing expression of CD36","volume":"67","author":"Guo","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib204","article-title":"CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes","volume":"v448","author":"Angin","year":"2012","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib205","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ. Res."},{"issue":"6801","key":"10.1016\/j.phrs.2022.106152_bib206","doi-asserted-by":"crossref","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib207","doi-asserted-by":"crossref","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib208","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvaa287","article-title":"Angiogenesis after acute myocardial infarction","volume":"117","author":"Wu","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"6398","key":"10.1016\/j.phrs.2022.106152_bib209","doi-asserted-by":"crossref","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib210","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07524-x","article-title":"Dynamics of angiogenesis in ischemic areas of the infarcted heart","volume":"7","author":"Kobayashi","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2022.106152_bib211","first-page":"20821","article-title":"Puerarin accelerate scardiac angiogenesis and improves cardiac function of myocardial infarction by upregulating VEGFA, Ang-1 and Ang-2 in rats","volume":"8","author":"Ai","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib212","doi-asserted-by":"crossref","DOI":"10.1038\/74725","article-title":"Angiopoietin-1 protects the adult vasculature against plasma leakage","volume":"6","author":"Thurston","year":"2000","journal-title":"Nat. Med."},{"issue":"5322","key":"10.1016\/j.phrs.2022.106152_bib213","doi-asserted-by":"crossref","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib214","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1248\/bpb.29.945","article-title":"Puerarin induces angiogenesis in myocardium of rat with myocardial infarction","volume":"29","author":"Zhang","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2022.106152_bib215","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/549412","article-title":"Hypoxia-Inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies","volume":"2015","author":"Zimna","year":"2015","journal-title":"BioMed. Res. Int."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2022.106152_bib216","article-title":"The effect of puerarin on serum nitric oxide concentration and myocardial eNOS expression in rats with myocardial infarction","volume":"10","author":"Zhang","year":"2008","journal-title":"J. Asian Nat. Prod. Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106152_bib217","article-title":"A mechanism for modulation of cellular responses to VEGF: activation of the integrins","volume":"6","author":"Byzova","year":"2000","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib218","doi-asserted-by":"crossref","DOI":"10.1172\/JCI117557","article-title":"Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P","volume":"94","author":"Ziche","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.phrs.2022.106152_bib219","doi-asserted-by":"crossref","DOI":"10.1038\/sj.cdd.4400581","article-title":"Nitric oxide - an endothelial cell survival factor","volume":"6","author":"Dimmeler","year":"1999","journal-title":"Cell Death Differ."},{"issue":"3","key":"10.1016\/j.phrs.2022.106152_bib220","first-page":"210","article-title":"Comparative study on effects of puerarin and granulocyte colony-stimulating factor in treating acute myocardial infarction","volume":"25","author":"zhong Xiao","year":"2005","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"9","key":"10.1016\/j.phrs.2022.106152_bib221","first-page":"790","article-title":"Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction","volume":"24","author":"zhong Xiao","year":"2004","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"6","key":"10.1016\/j.phrs.2022.106152_bib222","first-page":"339","article-title":"Effect of puerarin on plasma endothelin, renin activity and angiotensin II in patients with acute myocardial infarction","volume":"17","author":"Li","year":"1997","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"12","key":"10.1016\/j.phrs.2022.106152_bib223","first-page":"895","article-title":"Myocardial protection and mechanism of Puerarin injection on patients of coronary heart disease with ischemia\/reperfusion","volume":"23","author":"Xie","year":"2003","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"5","key":"10.1016\/j.phrs.2022.106152_bib224","first-page":"282","article-title":"Clinical study of puerarin in treatment of patients with unstable angina","volume":"18","author":"Zhao","year":"1998","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib225","first-page":"21","article-title":"Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease","volume":"22","author":"Shi","year":"2002","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"1","key":"10.1016\/j.phrs.2022.106152_bib226","first-page":"31","article-title":"Effect of Puerarin on platelet activating factors CD63 and CD62P, plasminogen activator inhibitor and C-reactive protein in patients with unstable angia pectoris","volume":"21","author":"Luo","year":"2001","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"issue":"2","key":"10.1016\/j.phrs.2022.106152_bib227","first-page":"176","article-title":"Effect of puerarin on heart function and serum oxidized-LDL in the patients with chronic cardiac failure","volume":"25","author":"Duan","year":"2000","journal-title":"Bull. Hunan Med. Univ."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:31:10Z","timestamp":1760913070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":227,"alternative-id":["S1043661822000974"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106152","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of puerarin in pathological cardiac remodeling: A review","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106152"}}